Bañobre Group

Bañobre Group

The Bañobre Research Group focus is nanomedicine for the development of diagnostic and therapeutic approaches towards an early and unequivocal diagnosis and treatment of cancer, inflammatory and neurological diseases. The Bañobre Group works in close collaboration with the clinic to enable translational medical research and to approach the end-user, in an attempt to offer a better prognosis and personalized treatment. To this aim, the Bañobre Group covers from fundamental research on the identification and validation of diseases’ biomarkers and cellular interactions, to a more applied cross-disciplinary research focused on the development of technologies and nanostructures (inorganic, organic, hybrid) for precision disease diagnosis, therapy and theranostics, ranging from low to high technology readiness levels (TRLs).

The nanomedicine field of action comprises in vitro (2D, 3D, OoC), ex vivo and in vivo experimentation and evolves in the frontier between Chemistry, Materials Science, Biophysics, Engineering and Biology, always within an international framework.

Nanomedicine evolves in the frontier between different disciplines of knowledge, such as chemistry, materials science, physics and biology, always within an international framework.

Research lines:

  • Theranostic probes
  • Animal‐free validation platforms

Team

Alumni

Projects

PROMISEANG

Alternative PROteins from MIcrobial fermentation of non-conventional SEA sources for Next-Generation food, feed and non-food bio-based applications

CiNTech

CiNTech: Polo Tecnológico de Inovação, Translação e Industrialização de Medicamentos Injetáveis Complexos

HfPT

Health from Portugal

IBEROSmais

INSTITUTO DE BIOFABRICATION EN RED PARA EL ENVEJECIMIENTO SALUDABLE

UnTAM

Unleashing tumour associated macrophages to win the fight against cancer

CRYSTAL3

Commercial & Research Opportunity for Cysteinyl Leukotriene Signalling in Ocular & CNS Dysfunction, Cancer and Cardiovascular Disease

BrainChip4MED

Brain-on-a-chip as a preclinical model tool for the screening of theranostic nanoformulations for neurodegenerative diseases

PANA

PROMOTING ACTIVE AGEING: FUNCTIONAL NANOSTRUCTURES FOR ALZHEIMER’S DISEASE AT ULTRA-EARLY STAGES

Publications

Related News